Curis, Inc.
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, whic…
Biotechnology
US, Lexington [HQ]
Earnings Call Transcripts
Earnings Call · Transcripts · SpeakersThis analysis tool shows transcript versions of the official earnings calls hosted by Curis, Inc.
Could not find a transcript
Peer Group
-
Sorry! None of CRIS's peers has listed transcripts.
Upcoming Transcript Tools
- Full Text Search - Across All Transcripts
- Detail Speaker Profiles
- Non-US Transcripts